RESPIRATORY SYNCYTIAL VIRUS (RSV)
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS (RSV) explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS (RSV) trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One appointment, two vaccines: RSV and shingles combo studied in older adults
⭐️ VACCINE ⭐️ CompletedThis study looked at whether giving the RSV vaccine and the shingles vaccine at the same time is safe and works well in adults aged 50 and older. About 526 healthy or stable participants received either both vaccines together or one alone. Researchers measured immune responses an…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 16, 2026 12:51 UTC
-
New RSV vaccine study aims to shield nursing home residents
⭐️ VACCINE ⭐️ CompletedThis study looked at how well new RSV vaccines work in adults over 60 who live in nursing homes compared to those living independently. Researchers measured immune responses in 152 participants to see if the vaccines protect both groups equally. The goal is to ensure vulnerable o…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE4 • Sponsor: University of Rochester • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 15, 2026 18:57 UTC
-
RSV vaccine study aims to make shots easier to store and use
⭐️ VACCINE ⭐️ CompletedThis study tested an RSV vaccine in 453 healthy women aged 18-49 to see if a multidose vial with a preservative works as well as a single-dose vial. The vaccine helps the body build defenses against RSV, a virus that can cause serious breathing problems. Participants received one…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 12, 2026 12:06 UTC